Athens Medical Centre (FRA:ACS) Marketable Securities: €0.3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ACS Athens Medical Centre SA FRA:ACS
62 GF Score
Price €1.50
GF Value €1.75
! 8 Warning Signs
View Full Analysis

What is Athens Medical Centre Marketable Securities?

Athens Medical Centre FRA:ACS +2.74% 62 Marketable Securities is €0.3 Mil as of Dec. 2025. GuruFocus rates FRA:ACS with a GF Score™ of 62/100 and a GF Value™ of €1.75. The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Athens Medical Centre's Marketable Securities for the quarter that ended in Dec. 2025 was €0.3 Mil.

Athens Medical Centre's annual Marketable Securities stayed the same from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) but then increased from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€0.3 Mil).

Athens Medical Centre  (FRA:ACS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Athens Medical Centre Marketable Securities Related Terms

Athens Medical Centre Marketable Securities Historical Data

* Premium members only.

The historical data trend for Athens Medical Centre's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre Marketable Securities Chart

Athens Medical Centre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.25

Athens Medical Centre Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.18 0.25
FRA:ACS
62GF Score
Athens Medical Centre SA FRA:ACS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athens Medical Centre Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.3 Mil mean?
Athens Medical Centre (FRA:ACS) has a Marketable Securities of €0.3 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Athens Medical Centre and its competitors.
Is Athens Medical Centre's Marketable Securities too high?
Athens Medical Centre's current Marketable Securities is €0.3 Mil. Overall, Athens Medical Centre has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's Marketable Securities compare to HCA and THC?
Athens Medical Centre's Marketable Securities of €0.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Athens Medical Centre and its competitors. Athens Medical Centre's current Marketable Securities is €0.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Athens Medical Centre (FRA:ACS) has a current Marketable Securities of €0.3 Mil. The stock's GF Value™ is €1.75, compared to a current price of €1.50 — trading 14.3% below its estimated fair value. The current Marketable Securities is €0.3 Mil. Athens Medical Centre's overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current Marketable Securities is €0.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.50 is trading 14.3% below its estimated GF Value™ of €1.75.

Key valuation signals for FRA:ACS:

  • Marketable Securities: €0.3 Mil
  • GF Value™: €1.75 vs. price of €1.50 (14.3% below fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Athens Medical Centre Business Description

Other Exchanges IATR:Greece
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
62GF Score

Get the complete analysis for FRA:ACS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.50
Price
€1.75
GF Value